MEG3 in hematologic malignancies: from the role of disease biomarker to therapeutic target

Pharmacogenetics and Genomics · Published 2024-05-14 · DOI 10.1097/fpc.0000000000000534

Authors being retrieved — see the publisher record. https://doi.org/10.1097/fpc.0000000000000534

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2024

Related articles